Follow
Budiwan Sumarsono
Budiwan Sumarsono
astellas
Verified email at astellas.com
Title
Cited by
Cited by
Year
Prevalence of overactive bladder in C hina, T aiwan and S outh K orea: R esults from a cross‐sectional, population‐based study
YC Chuang, SP Liu, KS Lee, L Liao, J Wang, TK Yoo, R Chu, ...
LUTS: Lower Urinary Tract Symptoms 11 (1), 48-55, 2019
982019
Prevalence of lower urinary tract symptoms in China, Taiwan, and South Korea: results from a cross-sectional, population-based study
C Chapple, D Castro-Diaz, YC Chuang, KS Lee, L Liao, SP Liu, J Wang, ...
Advances in Therapy 34, 1953-1965, 2017
982017
Mirabegron add-on therapy to tamsulosin for the treatment of overactive bladder in men with lower urinary tract symptoms: a randomized, placebo-controlled study (MATCH)
H Kakizaki, KS Lee, O Yamamoto, JJ Jong, D Katou, B Sumarsono, S Uno, ...
European urology focus 6 (4), 729-737, 2020
622020
The prevalence of lower urinary tract symptoms in population aged 40 years or over, in South Korea
TK Yoo, KS Lee, B Sumarsono, ST Kim, HJ Kim, HC Lee, SH Kim
Investigative and clinical urology 59 (3), 166, 2018
442018
Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population …
KS Lee, TK Yoo, L Liao, J Wang, YC Chuang, SP Liu, R Chu, ...
BMC urology 17, 1-10, 2017
382017
Epidemiology of lower urinary tract symptoms in a cross-sectional, population-based study: The status in China
JY Wang, L Liao, M Liu, B Sumarsono, M Cong
Medicine 97 (34), e11554, 2018
342018
The prevalence and bother of lower urinary tract symptoms in men and women aged 40 years or over in Taiwan
SP Liu, YC Chuang, B Sumarsono, HC Chang
Journal of the Formosan Medical Association 118 (1), 170-178, 2019
332019
The prevalence and risk factors of nocturia in China, South Korea, and Taiwan: results from a cross-sectional, population-based study
PM Chow, SP Liu, YC Chuang, KS Lee, TK Yoo, L Liao, J Wang, M Liu, ...
World Journal of Urology 36, 1853-1862, 2018
272018
Prevalence, severity, and associated factors in women in East Asia with moderate-to-severe vasomotor symptoms associated with menopause
Q Yu, HD Chae, SM Hsiao, J Xie, M Blogg, B Sumarsono, S Kim
Menopause 29 (5), 553-563, 2022
222022
The prevalence of urinary incontinence in men and women aged 40 years or over in China, Taiwan and South Korea: A cross‐sectional, prevalence‐based study
B Sumarsono, JJ Jong, JY Wang, L Liao, KS Lee, TK Yoo, SP Liu, ...
LUTS: Lower Urinary Tract Symptoms 12 (3), 223-234, 2020
172020
Effect of lower urinary tract symptoms on the quality of life and sexual function of males in China, Taiwan, and South Korea: Subgroup analysis of a cross‐sectional, population …
L Liao, YC Chuang, SP Liu, KS Lee, TK Yoo, R Chu, B Sumarsono, ...
LUTS: Lower Urinary Tract Symptoms 11 (2), O78-O84, 2019
172019
Utilization of cryopreserved sperm cells based on the indication for storage
TK Yoo, KS Lee, B Sumarsono, ST Kim, HJ Kim, HC Lee, SH Kim, ...
Investigative and Clinical Urology 59 (3), 177-181, 2018
112018
Cardiovascular safety of mirabegron add‐on therapy to tamsulosin for the treatment of overactive bladder in men with lower urinary tract symptoms: A post hoc analysis from the …
T Katoh, H Kakizaki, KS Lee, K Ishida, D Katou, O Yamamoto, JJ Jong, ...
LUTS: Lower Urinary Tract Symptoms 13 (1), 98-107, 2021
32021
EFFICACY AND SAFETY OF ADD-ON MIRABEGRON VS. PLACEBO TO TAMSULOSIN IN MEN WITH OVERACTIVE BLADDER SYMPTOMS (MATCH STUDY): LBA13
H Kakizaki, KS Lee, O Yamamoto, JJ Jong, D Katou, B Sumarsono, S Uno, ...
Journal of Urology 199 (4), e988, 2018
32018
A treatment prediction strategy for overactive bladder using a machine learning algorithm that utilized data from the FAITH study
F Hadi, B Sumarsono, KS Lee, SJ Oh, ST Cho, YC Hsu, P Rasner, ...
Neurourology and Urodynamics 42 (6), 1227-1237, 2023
22023
Mirabegron add-on therapy to tamsulosin in men with overactive bladder: post hoc analyses of efficacy from the MATCH study
H Kakizaki, KS Lee, D Katou, O Yamamoto, B Sumarsono, S Uno, ...
Advances in Therapy 38, 739-757, 2021
22021
Safety and efficacy of an α1‐blocker plus mirabegron compared with an α1‐blocker plus antimuscarinic in men with lower urinary tract symptoms secondary to …
S Herschorn, T Tarcan, YH Jiang, E Chung, F Abdul Hadi, A Steup, ...
Neurourology and Urodynamics, 2024
12024
300 A TREATMENT PREDICTION STRATEGY FOR OVERACTIVE BLADDER USING A MACHINE LEARNING ALGORITHM THAT UTILISED DATA FROM THE FAITH STUDY
FA Hadi, B Sumarsono, Y Hsu, S Cho, K Lee, S Oh, P Rasner
Continence 2, 100366, 2022
12022
Safety of tacrolimus in autoimmune disease: results from post-marketing surveillance in south korea
WH Yoo, SI Lee, TH Kim, JJ Sung, SM Kim, F Hua, B Sumarsono, SH Park
Journal of rheumatic diseases 28 (4), 202, 2021
12021
Efficacy and safety of add-on mirabegron vs placebo to tamsulosin in men with overactive bladder symptoms (match study)
KS Lee, H Kakizaki, O Yamamoto, JJ Jong, D Katou, B Sumarsono, S Uno, ...
INTERNATIONAL JOURNAL OF UROLOGY 26, 65-65, 2019
12019
The system can't perform the operation now. Try again later.
Articles 1–20